NIH-funded research R21 grant

Exploring how retroviruses can enhance the immune system's ability to fight infections

Official title: Reverse transcriptase-mediated expansion of the host innate immune system

Funded at Pacific Northwest Research Institute · NIH-10753557 · Data updated 2026-11-12

This study is looking at how certain immune genes, which come from retroviruses, can help our bodies fight off viral infections better, and it's for anyone interested in understanding why some people get sick more easily than others.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionPacific Northwest Research Institute
NIH-funded
Lab location1 site (Seattle, United States)
Project startDecember 12, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$276,000
NIH project number5R21AI174130-02
Project IDNIH-10753557 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with varying susceptibility to viral infections, particularly those with a family history of infectious diseases.

Less likely to help

Patients with no history of viral infections or those who do not have genetic variations in innate immunity may not benefit from this research.

What this research studies

This research investigates the role of newly identified immune genes, created by retroviruses, in enhancing the body's response to viral infections. By examining genetic variations in these retrocopies, the study aims to understand how they influence individual susceptibility to diseases. The approach involves advanced genetic sequencing techniques to identify and analyze these retrocopies in human and primate genomes. This could lead to new insights into immune responses and potential therapeutic targets for infectious diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing and treating viral infections by harnessing the body's innate immune responses.

How similar studies have gone: Previous studies have shown promise in understanding the role of genetic variations in immune responses, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Pacific Northwest Research Institute
    Seattle, United States
    Active

Researchers

  • Principal investigator: Mclaughlin, Richard Noel — Pacific Northwest Research Institute
  • Study coordinator: Mclaughlin, Richard Noel

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.